Press Releases

Press Releases

Date Title Files

Apr 02, 2019

Dynavax Presents Phase 1b Data on Inhaled DV281 TLR9 Agonist at the 2019 AACR Annual Meeting

Apr 01, 2019

Dynavax’s SD-101 and 4SC’s Domatinostat Demonstrate Synergy and Induce a Systemic Anti-tumor Response in Preclinical Models

Mar 28, 2019

Dynavax Announces European Medicines Agency Accepts Marketing Authorization Application for HEPLISAV-B® for Prevention of Hepatitis B in Adults

Mar 20, 2019

Dynavax to Present on Inhaled TLR9 Agonist DV281 at the AACR Annual Meeting 2019

Mar 18, 2019

Dynavax Exercises Option for $75 Million in Non-Dilutive Debt

Mar 06, 2019

Dynavax to Present at 39th Annual Cowen Healthcare Conference

Feb 26, 2019

Dynavax Announces Fourth Quarter and Full Year 2018 Financial Results

Feb 12, 2019

Dynavax Technologies to Report Fourth Quarter and Full Year 2018 Financial Results and Host Conference Call on February 26

Jan 29, 2019

Heather Rowe Named Dynavax’s Vice President of Investor Relations and Corporate Communications

Jan 08, 2019

Sam’s Club and Dynavax Technologies Corporation Announce Collaboration to Make HEPLISAV-B® [Hepatitis B Vaccine (Recombinant), Adjuvanted] Available to Sam’s Club Patients